http://1.usa.gov/MLAXIURead More

http://www.fda.gov/cdrh/mdufma/guidance/agenda/fy08.html#2Read More

http://www.fda.gov/cdrh/osel/guidance/321.pdfRead More

/docs/FDAOIVD-IVDMIAdraftguidance072507.pdfRead More

/Docs/PulseOximeterDraftGuidance071907.pdfRead More

This content is only available to Premium and higher subscribers.  See our Subscribe page for information on subscriptions. Our SoftwareCPR audit checklist for assessing conformance with the FDA Guidance for "Computerized Systems Used in Clinical Trials" can be viewed and downloaded at this link:  ClinicalTrialsSWFullChecklist. This checklist has been updated by Mary Decareau of SoftwareCPR to reflect...Read More

This content is only available to Premium and higher subscribers.  See our Subscribe page for information on subscriptions. 21 CFR Part 11 is a topic of current focus for FDA and industry. In February 2003 FDA announced a major change in direction regarding Part 11 and withdrew all previous draft Part 11 guidance and the Part 11...Read More

/Docs/FDAClinicalTrialsComputerSystemGuidance-051007-04d-0440-gdl0002.pdfRead More

/Docs/ComputerizedLaborMonitoringSystemClassificationRule042407.pdfRead More

/Docs/ComputerizedLaborMonitoringSystemGuidance042407.pdfRead More

/docs/JMurrayPresentation-softwarecompliancescienceMarch2007.pdfRead More

/docs/FDAComplementaryandAlternativeMedicineProductsDraft2006.pdfRead More

/docs/CBERaccessoriesIVD0506.pdfRead More

/docs/IVDDFDARegulationofSoftwarePresentation1106.pdfRead More

/Docs/FDAJMurray-SoftwareDesignControls041006.pdfRead More

/docs/Part11AdvaMednov82006finalA.pdfRead More

http://1.usa.gov/1fH22MnRead More

/docs/FDAPortableInvasiveGlucoseMonitoring-DraftGuidance102406.pdfRead More

FDA’s Center for Biologics Evaluation and Research issued the following: “Compliance Program Inspection of Human Cells, Tissues, and Cellular and Tissue-Based Products (HCT/Ps) 7341.002” This guide mentions software and computer systems in one paragraph which is provided below: “Computers: The performance of computer software must be validated (if customized) or verified (if used “off-the-shelf”) for...Read More

/Docs/BloodBank-FDA-CBER-CPG-0906.pdfRead More

FDA announced in the Federal Register (Docket No. 1992S–0251) a central Gateway/single point of entry for electronic submissions for device, drug and biologic applications. It is referred to as the Electronic Submission Gateway (ESG). The announcement describes three secure options for electronic submissions: “The FDA ESG offers two secure communication options for applicants that have...Read More

/docs/FDABayesianStatisticsDraftGuidance052306.pdfRead More

http://www.fda.gov/cdrh/oivd/presentations/042004-callaghan-software.html#footnote_2Read More

http://www.fda.gov/ForIndustry/FDAeSubmitter/default.htmRead More

/docs/GHTF-QSRiskMgmtGuidance-sg3n15r82005.pdfRead More

/docs/TransfusionSafteyManagementSystems-FDApresentation09-Mar-06.pdfRead More

This content is only available to Premium and higher subscribers.  See our Subscribe page for information on subscriptions. This reference manual includes the following documents in a single pdf with bookmarks and a clickable TOC. Be sure to click bookmarks in adobe so you can jump around the document easily. This pdf contains key FDA software guidances...Read More

/docs/FDA-PATPresentationwatts_3_2005.pdfRead More

http://www.fda.gov/OHRMS/DOCKETS/98fr/05-22267.pdfRead More

http://www.21cfrpart11.com/pages/sol_prov/solution_providers.htmRead More

/Docs/ADVAMEDSoftware513(g)sFDASlides110205.pdfRead More

/docs/FDASoftwareSubmissionGuidance.pdfRead More

/docs/FDABFitzgeralsPresentationLondon04-2005.pdfRead More

http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/Guidances/ucm072331.pdfRead More

http://www.fda.gov/ohrms/dockets/dockets/04p0429/04p-0429-let0001-vol1.pdfRead More

/docs/FDA040105-kesslerRiskInitiative.pdfRead More

/Docs/FDAImplantableIDguidance1541.pdfRead More

/docs/FDACybersecurityHealthcareOrganizationFAQ.pdfRead More

http://www.fda.gov/cdrh/osel/programareas/software.htmlRead More

/Docs/FDAmeetingsbestprac04.pptRead More

/docs/510kAssistedReproductionLaserSystems-122804.pdfRead More

/Docs/ElectronicLabeling-mdufmasummary112304.pdfRead More

/Docs/PlasmaInspections7342002bld-SCPRcomputerhighlights.pdfRead More

The following question was asked during the “Ask the FDA” session (326-QE) on 10/25/04 at the AABB Annual Meeting held in Baltimore, MD as reported by SoftwareCPR Partner Molly Ray: When blood establishment computer software manufacturers distribute their device (software) for beta testing, they are required to label the software in accordance with the IDE...Read More

While FDA regulates Blood Establishment Computer Systems (BECS) as medical devices as well as regulating the blood establishments themselves, many other countries take a different approach. In Canada the blood establishment is regulated. Computer systems used in donor establishments are not considered medical devices and are regulated through the establishment licensing process. Unlike with the...Read More

/docs/CancelCellDetectionDeviceGuidance0904-Doc1531.pdfRead More

/docs/Part11meetingnoticeJune2004-04-7942.pdfRead More

/docs/barcodelabelrule0304.pdfRead More

FDA has been investigating putting together information on hazards of various types of devices as an aide to both FDA and industry. Sandy Weininger at CDRH has established a forum for dissemination of information on this project. If you are interested in participating or receiving updates on this effort send email to office@softwarecpr.com or directly...Read More

/docs/DNAMutationDetectionSystems.pdfRead More